Rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in diffuse large B-cell lymphoma

BACKGROUND: Diffuse large B-cell lymphoma (DLBCL) is the most frequent non-Hodgkin lymphoma worldwide. The current standard of care is chemoimmunotherapy with an R-CHOP regimen. We aim to review the role of this regimen after two decades of being the standard of care. METHODS: A comprehensive litera...

Descripción completa

Detalles Bibliográficos
Autores principales: Candelaria, Myrna, Dueñas-Gonzalez, Alfonso
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7970687/
https://www.ncbi.nlm.nih.gov/pubmed/33796235
http://dx.doi.org/10.1177/2040620721989579

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7970687/
https://www.ncbi.nlm.nih.gov/pubmed/33796235
http://dx.doi.org/10.1177/2040620721989579

Ejemplares similares